MASH and MASLD are prevalent, complex diseases often accompanied by metabolic comorbidities like obesity and diabetes. GLP-1 receptor agonists, such as semaglutide, show promise in resolving NASH ...

Souza M, Al-Sharif L, Diaz I, et al. Representation of sex, race and ethnicity in mash randomised controlled trials: a systematic review and meta-analysis. Liver Int . 2025;45(4):e70029. doi:10. ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

While talking about Maharashtrian cuisine, you can find a special place of poha or pohe that is packed with aloo or batata. Also Read: Cutlets To Idli, 7 Poha Breakfast Recipe Ideas To Start Your Day ...